Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis

Clinical Infectious Diseases

Volumn 33, Issue 5, 2001, Pages 676-685

  Thompson, Charles ^a  

^a Farmington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BABESIOSIS; COMORBIDITY; DEER; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; EHRLICHIOSIS; HOST PARASITE INTERACTION; HUMAN; INCIDENCE; INFECTION RISK; LYME DISEASE; NONHUMAN; PRIORITY JOURNAL; SYNDROME DELINEATION; TICK BORNE DISEASE; TREATMENT PLANNING; ZOONOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BABESIOSIS; COMORBIDITY; DEER; DIAGNOSIS, DIFFERENTIAL; DISEASE RESERVOIRS; DRUG THERAPY, COMBINATION; EHRLICHIOSIS; HUMANS; LYME DISEASE; UNITED STATES; ZOONOSES;

EID: 0035451704     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/322681     Document Type: Article

References (118)

1. Ecology of Ixodes dammini-borne human babesiosis and Lyme disease
2. Lyme disease
3. Concurrent Lyme disease and babesiosis: Evidence for increased severity, and duration of illness
4. Human granulocytic ehrlichiosis in the upper midwest United States: A new species emerging?
5. Human granulocytic ehrlichiosis in Massachusetts
6. Role of deer in the epizootiology of Babesia microti in Massachusetts, U.S.A.
7. Serologic evidence for simultaneous occurrences of Lyme disease and babesiosis
8. Simultaneous occurrence of babesiosis and Lyme disease
9. Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis: Demonstration of spirochetes in the myocardium
10. Fever and headache in a splenectomized woman
11. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis
12. Increased severity, of Lyme disease illness due to concurrent babesiosis and ehrlichiosis
13. Clinical and epidemiological features of early Lyme disease and HGE in Wisconsin
14. Lyme disease and human babesiosis: Evidence incriminating vector and reservoir hosts
15. Babesiosis in a Massachusetts resident
16. Babesiosis
17. Sur l'hemoglubinurie bacterienne boeuf
18. Investigation into the nature, causation, and prevention of southern cattle fever
19. Human babesiosis on Nantucket Island: Transmission by nymphal Ixodes ticks
20. Human babesiosis: Reservoir of infection on Nantucket Island
21. Erythema chronicum migrans
22. Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities
23. Lyme disease: A tick-borne spirochetosis?
24. Studies on the causative agent of "Hyaganetsu" disease. I. Isolation of the agent and its inoculation trial in human beings
25. Human infection with Ehrlichia canis, a leukocyte rickettsia
26. Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis
27. Studies on the infectious agent of tick-borne fever in sheep
28. Cytoecetes microti, n.g., n.sp., a parasite developing in granulocytes and infective for small rodents
29. Human granulocytic ehrlichiosis in Western Europe
30. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis
31. Tickborne encephalitis
32. A focus of deer tick virus transmission in the north-central United States
33. Detection of the agents of human ehrlichioses in ixodid ticks from California
34. Coexistence of ehrlichiae of the phagocytophila group with Borrelia burgdorferi in Ixodes ricinus from Southern Germany
35. Detection of the agent of human granulocytic ehrlichiosis (HGE) in UK ticks using polymerase chain reaction
36. Reservoir hosts of human babesiosis on Nantucket Island
37. Borrelia burgdorferi and Babesia microti: Efficiency of transmission from reservoirs to vector ticks (Ixodes dammini)
38. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle
39. Arthritis caused by Borrelia burgdorferi in dogs
40. Ehrlichiosis: Ticks, dogs, and doxycycline
41. The impact of cultured and environmental changes on the epidemiology and control of human babesiosis
42. Reduced abundance of immature Ixodes dammini (Acari: Ixodidae) following elimination of deer
43. Natural distribution of the Ixodes dammini spirochetes
44. Prevalence of tick-borne pathogens in Ixodes scapularis in a rural New Jersey County
45. Concurrent Borrelia burgdorferi and Babesia microti infection in nymphal Ixodes dammini
46. Geographic risk for Lyme disease and human granulocytic ehrlichiosis in southern New York State
47. Coinfection of black-legged ticks (Acari: Ixodidae) in Dutchess County, New York, with the agents of Lyme disease and human granulocytic ehrlichiosis
48. Prevalence of Borrelia burgdorferi and granulocytic and monocytic ehrlichiae in Ixodes ricinus ticks from southern Germany
49. Molecular evidence of coinfection of ticks with Borrelia burgdorferi sensu lato and the human granulocytic agent in Switzerland
50. Infection with the agents of human granulocytic ehrlichiosis, Lyme disease, and babesiosis in white-footed mice (Peromyscus leucopus) in Connecticut
51. Babesia microti, human babesiosis, and Borrelia burgdorferi in Connecticut
52. Peromyscus leucopus and Microtus pennsylvanicus simultaneously infected with Borrelia burgdorferi and Babesia microti
53. Cosegregation of a novel Bartonella species with Borrelia burgdorferi and Babesia microti in Peromyscus leucopus
54. Infections with Babesia canis and Ehrlichia canis in dogs in Zimbabwe
55. Concurrent babesiosis and ehrlichiosis in the dog: Blood smear examination supplemented by the indirect fluorescent antibody test, using Cowdria ruminantium as antigen
56. Coinfection with multiple tick-borne pathogens in a Walker-Hound kennel in North Carolina
57. Infections of granulocytic ehrlichiae and Borrelia burgdorferi in white-tailed deer in Connecticut
58. Lyme disease - United States, 1999
59. Human babesiosis in New York state: An epidemiologic description of 136 cases
60. Babesiosis: An underdiagnosed disease of children
61. Infection with a Babesia-like organism in the western United States
62. A fatal case of babesiosis in Missouri: Identification of another piroplasm that infects humans
63. Human babesiosis
64. Successful chemotherapy of transfusion babesiosis
65. Transfusion-transmitted babesiosis: A case report from a new epidemic area
66. Babesiosis in a renal transplant recipient acquired through blood transfusion
67. Ehrlichial diseases of humans: Emerging tickborne infections
68. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis
69. Geographical and temporal distribution of babesiosis in Connecticut
70. Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera
71. Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States
72. Human granulocytic ehrlichiosis in Bulgaria
73. Immunoserologic evidence of human granulocytic ehrlichiosis in Danish patients with Lyme neuroborreliosis
74. Serological evidence of human granulocytic ehrlichiosis in Switzerland
75. Serological evidence of human granulocytic ehrlichiosis in Norway
76. Two tick-borne diseases in one: A case report of concurrent babesiosis and Lyme disease in Ontario
77. A case of concurrent Lyme meningitis with ehrlichiosis
78. A case of concurrent presentation of human ehrlichiosis and Lyme disease in Connecticut
79. Lyme disease with concurrent ehrlichiosis
80. Coinfection with Babesia microti and Borrelia burgdorferi in a western Wisconsin resident
81. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic ehrlichia species in residents of Wisconsin and Minnesota
82. Acquisition of coinfection and simultaneous transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis ticks
83. Cardiac seqeulae of Lyme disease: Simulation in the balb/c mouse
84. Immunodepression in Babesia microti infections
85. Babesia
86. Human babesiosis on Nantucket Island
87. Human babesiosis on Nantucket Island: Evidence for self-limited and subclinical infections
88. Morphologic and clinical observations in human infection with Babesia microti
89. Persistent parasitemia following acute babesiosis
90. Self-limited babesiosis in splenectomized child
91. Babesiosis in splenectomized adults: Review of 22 reported cases
92. Relative bradycardia and lymphopenia in patients with babesiosis
93. Babesiosis in patients with AIDS: A chronic infection presenting as fever of unknown origin
94. Babesiosis
95. Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment
96. Diagnosis of Lyme disease based on dermatologic manifestations
97. Dermatologic manifestations of Lyme disease
98. The long-term course of Lyme arthritis in children
99. Lyme disease - Pediatric perspective
100. Chronic neurologic manifestations of Lyme disease
101. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease
102. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans
103. A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden
104. Coexposure to Borrelia bugdorferi and Babesia microti does not worsen the long-term outcome of Lyme disease
105. Western blotting in the serodiagnosis of Lyme disease
106. Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice
107. Diagnosis of babesiosis: Evaluation of a serologic test for the detection of Babesia microti antibody
108. Efficacy of an IgM serodiagnostic test for the rapid diagnosis of acute babesiosis
109. Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HE-44-based enzyme-linked immunosorbent assay
110. Serologic testing for human granulocytic ehrlichiosis at a national referral center
111. Target imbalance: Disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients
112. Detection of Babesia microti by polymerase chain reaction
113. Practice guidelines for the treatment of Lyme disease
114. Atovaquone and azithromycin for the treatment of human babesiosis
115. Treatment of transfusion-transmitted babesiosis by exchange transfusion
116. Ehrlichia chaffeensis (human monocytotrophic ehrlichiosis), Ehrlichia phagocytophila (human granulocytotropic ehrlichiosis), and other ehrlichiae
117. Doxycycline use for rickettsial disease in pediatric patients
118. Doxycycline and staining of permanent teeth